Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms

Elife. 2014 May 27;3:e02200. doi: 10.7554/eLife.02200.

Abstract

The p53 transcription factor is a potent suppressor of tumor growth. We report here an analysis of its direct transcriptional program using Global Run-On sequencing (GRO-seq). Shortly after MDM2 inhibition by Nutlin-3, low levels of p53 rapidly activate ∼200 genes, most of them not previously established as direct targets. This immediate response involves all canonical p53 effector pathways, including apoptosis. Comparative global analysis of RNA synthesis vs steady state levels revealed that microarray profiling fails to identify low abundance transcripts directly activated by p53. Interestingly, p53 represses a subset of its activation targets before MDM2 inhibition. GRO-seq uncovered a plethora of gene-specific regulatory features affecting key survival and apoptotic genes within the p53 network. p53 regulates hundreds of enhancer-derived RNAs. Strikingly, direct p53 targets harbor pre-activated enhancers highly transcribed in p53 null cells. Altogether, these results enable the study of many uncharacterized p53 target genes and unexpected regulatory mechanisms.DOI: http://dx.doi.org/10.7554/eLife.02200.001.

Keywords: PIG3; PUMA; eRNA; genomics; p21; tumor supressor.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / genetics
  • Binding Sites
  • Cell Line
  • Humans
  • Proto-Oncogene Proteins c-mdm2 / antagonists & inhibitors
  • RNA / metabolism
  • Transcription, Genetic / physiology*
  • Tumor Suppressor Protein p53 / metabolism
  • Tumor Suppressor Protein p53 / physiology*

Substances

  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • RNA
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2